Roche Holding AG RHHBY OTC

Roche Holding AG (RHHBY) reported total assets of $100.82B and total liabilities of $62.89B for fiscal year 2025, resulting in total equity of $37.92B.

The company held $15.49B in cash and short-term investments. Total debt stood at $31.67B, with net debt of $26.08B. The Debt-to-Equity (D/E) ratio was 0.84 (moderate).

Current ratio is 1.38, suggesting adequate short-term liquidity. Interest coverage is 14.3x (strong).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (94/100) — Total assets $100.82B and equity $37.92B support the company's competitive scale
• VALUE (46/100) — Debt-to-Equity 0.84 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 68/100 with 3/7 criteria passed.

AZN

AstraZeneca PLC

$204.38

+1.06%

MRK

Merck & Co., Inc.

$119.96

-0.16%

NVS

Novartis AG

$153.38

-0.71%

GILD

Gilead Sciences, Inc.

$140.45

+1.02%

GSK

GSK plc

$59.18

+0.41%

BMY

Bristol-Myers Squibb Company

$58.08

+0.03%

SNY

Sanofi

$47.64

+1.45%

LLY

Eli Lilly and Company

$922.50

-0.76%